IN2014DN10680A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN10680A IN2014DN10680A IN10680DEN2014A IN2014DN10680A IN 2014DN10680 A IN2014DN10680 A IN 2014DN10680A IN 10680DEN2014 A IN10680DEN2014 A IN 10680DEN2014A IN 2014DN10680 A IN2014DN10680 A IN 2014DN10680A
- Authority
- IN
- India
- Prior art keywords
- polymorphic forms
- crystalline polymorphic
- respiratory
- disease
- mdt
- Prior art date
Links
- BLUJRJMLDHEMRX-UHFFFAOYSA-N 2-[[2-hydroxy-5-[(5-methyltetrazol-1-yl)iminomethyl]phenyl]-(4-hydroxyphenyl)methyl]-4-[(5-methyltetrazol-1-yl)iminomethyl]phenol Chemical compound Cc1nnnn1N=Cc1ccc(O)c(c1)C(c1ccc(O)cc1)c1cc(C=Nn2nnnc2C)ccc1O BLUJRJMLDHEMRX-UHFFFAOYSA-N 0.000 abstract 1
- 241000725643 Respiratory syncytial virus Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261666258P | 2012-06-29 | 2012-06-29 | |
| PCT/US2013/048723 WO2014005098A2 (en) | 2012-06-29 | 2013-06-28 | Compositions and methods for treating or preventing pneumovirus infection and associated diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN10680A true IN2014DN10680A (enExample) | 2015-08-28 |
Family
ID=49778754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN10680DEN2014 IN2014DN10680A (enExample) | 2012-06-29 | 2013-06-28 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9040569B2 (enExample) |
| EP (1) | EP2867216A4 (enExample) |
| JP (1) | JP2015524391A (enExample) |
| KR (1) | KR20150037946A (enExample) |
| CN (1) | CN104507918A (enExample) |
| AU (1) | AU2013282286A1 (enExample) |
| BR (1) | BR112014032290A2 (enExample) |
| CA (1) | CA2877941A1 (enExample) |
| EA (1) | EA201590124A1 (enExample) |
| HK (2) | HK1210163A1 (enExample) |
| IL (1) | IL236476A0 (enExample) |
| IN (1) | IN2014DN10680A (enExample) |
| MX (1) | MX2014015340A (enExample) |
| NZ (1) | NZ628880A (enExample) |
| TW (1) | TWI516283B (enExample) |
| WO (1) | WO2014005098A2 (enExample) |
| ZA (1) | ZA201409073B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201590124A1 (ru) | 2012-06-29 | 2015-06-30 | Майкродоуз Терапьютикс, Инк. | Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний |
| JP2017537958A (ja) * | 2014-12-18 | 2017-12-21 | メトリオファーム アーゲー | ５−アミノ−２，３−ジヒドロフタラジン１，４−ジオンナトリウム塩の結晶形態、同一物を含む医薬製剤、及びこの形態の製造ための方法 |
| KR20180105129A (ko) * | 2015-11-30 | 2018-09-27 | 노부스 테라퓨틱스, 인크. | 이과학적 예방 및 치료를 위한 조성물 및 방법 |
| US10238821B2 (en) | 2016-10-11 | 2019-03-26 | Microdose Therapeutx, Inc. | Inhaler and methods of use thereof |
| US20200085741A1 (en) * | 2018-09-14 | 2020-03-19 | Pharmosa Biopharm Inc. | Pharmaceutical composition for controlled release of weak acid drugs and uses thereof |
| CN109827875A (zh) * | 2019-04-10 | 2019-05-31 | 上海市食品药品检验所 | 一种用于测定吸入制剂溶出度的装置和方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6495580B1 (en) | 1998-01-29 | 2002-12-17 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| CN1289248A (zh) * | 1998-01-29 | 2001-03-28 | 维洛药品公司 | 治疗或预防肺病毒感染及有关疾病的化合物、组合物和方法 |
| WO2002059132A1 (en) | 2001-01-26 | 2002-08-01 | Viropharma Incorporated | Intermediate compounds useful for making antiviral compounds |
| US8202896B2 (en) | 2002-08-09 | 2012-06-19 | Microdose Therapeutx, Inc. | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| EP1539691A2 (en) | 2002-08-09 | 2005-06-15 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| EA201590124A1 (ru) | 2012-06-29 | 2015-06-30 | Майкродоуз Терапьютикс, Инк. | Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний |
-
2013
- 2013-06-28 EA EA201590124A patent/EA201590124A1/ru unknown
- 2013-06-28 EP EP13809282.0A patent/EP2867216A4/en not_active Withdrawn
- 2013-06-28 AU AU2013282286A patent/AU2013282286A1/en not_active Abandoned
- 2013-06-28 IN IN10680DEN2014 patent/IN2014DN10680A/en unknown
- 2013-06-28 WO PCT/US2013/048723 patent/WO2014005098A2/en not_active Ceased
- 2013-06-28 US US13/931,201 patent/US9040569B2/en not_active Expired - Fee Related
- 2013-06-28 HK HK15110967.1A patent/HK1210163A1/xx unknown
- 2013-06-28 JP JP2015520598A patent/JP2015524391A/ja not_active Withdrawn
- 2013-06-28 NZ NZ628880A patent/NZ628880A/en not_active IP Right Cessation
- 2013-06-28 CN CN201380034589.0A patent/CN104507918A/zh active Pending
- 2013-06-28 MX MX2014015340A patent/MX2014015340A/es unknown
- 2013-06-28 BR BR112014032290A patent/BR112014032290A2/pt not_active IP Right Cessation
- 2013-06-28 CA CA2877941A patent/CA2877941A1/en not_active Abandoned
- 2013-06-28 HK HK15104634.7A patent/HK1203956A1/xx unknown
- 2013-06-28 KR KR20157002571A patent/KR20150037946A/ko not_active Withdrawn
- 2013-07-01 TW TW102123484A patent/TWI516283B/zh not_active IP Right Cessation
-
2014
- 2014-12-10 ZA ZA2014/09073A patent/ZA201409073B/en unknown
- 2014-12-25 IL IL236476A patent/IL236476A0/en unknown
-
2015
- 2015-04-10 US US14/683,935 patent/US9504672B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NZ628880A (en) | 2016-08-26 |
| HK1210163A1 (en) | 2016-04-15 |
| BR112014032290A2 (pt) | 2017-06-27 |
| EP2867216A2 (en) | 2015-05-06 |
| US9504672B2 (en) | 2016-11-29 |
| US9040569B2 (en) | 2015-05-26 |
| EA201590124A1 (ru) | 2015-06-30 |
| TW201416093A (zh) | 2014-05-01 |
| US20140005239A1 (en) | 2014-01-02 |
| CA2877941A1 (en) | 2014-01-03 |
| ZA201409073B (en) | 2016-08-31 |
| CN104507918A (zh) | 2015-04-08 |
| KR20150037946A (ko) | 2015-04-08 |
| US20150209328A1 (en) | 2015-07-30 |
| IL236476A0 (en) | 2015-02-26 |
| TWI516283B (zh) | 2016-01-11 |
| AU2013282286A1 (en) | 2015-01-22 |
| WO2014005098A2 (en) | 2014-01-03 |
| MX2014015340A (es) | 2015-03-05 |
| WO2014005098A3 (en) | 2014-02-27 |
| JP2015524391A (ja) | 2015-08-24 |
| EP2867216A4 (en) | 2015-12-09 |
| HK1203956A1 (en) | 2015-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA033455B1 (ru) | Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе | |
| PL2791093T3 (pl) | Sposób wytwarzania 2,3,3,3-tetrafluoropropenu | |
| HK1207306A1 (en) | Modified polynucleotides for the production of proteins associated with human disease | |
| IL230635A (en) | An outgrowth of 4,3,2,1-tetrahydroquinoline used to treat diabetes | |
| WO2012025944A3 (en) | Sitagliptin, salts and polymorphs thereof | |
| IL216935A0 (en) | Process for the preparation of nacre mechano-structured by mechanosynthesis, mechano-structured nacre thus obtained and uses thereof | |
| FR2962731B1 (fr) | Procede de preparation de derives d'amino-benzoyl-benzofurane | |
| WO2014072961A3 (en) | Polymorphic forms of suvoroxant | |
| EP2738153A4 (en) | PROCESS FOR PREPARING 3,3-DIMETHYL-BUTYRALDEHYDE | |
| HUP1100701A2 (en) | Novel process for the preparation of travoprost | |
| MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
| WO2013014665A8 (en) | Intermediate compounds and process for the preparation of lurasidone and salts thereof | |
| MY191352A (en) | Aldosterone synthase inhibitors | |
| MX2014015340A (es) | Composiciones y metodos para tratar o evitar infeccion por pneumovirus y enfermedades asociadas. | |
| WO2015068175A3 (en) | An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof | |
| EA201300647A1 (ru) | Оптимизированный синтез чистых неполиморфных кристаллических жёлчных кислот с заданным размером частиц | |
| WO2015052568A3 (en) | Solid forms of curcumin and derivatives thereof | |
| WO2010079045A3 (en) | Crystalline salt forms of flibanserine | |
| PL2797863T5 (pl) | Sposób wytwarzania 1,3-butadienu | |
| WO2011100282A3 (en) | Imatinib mesylate polymorphs | |
| PL2581193T3 (pl) | Sposób wytwarzania implantów lub produktów pośrednich takich implantów, jak również implanty i produkty pośrednie otrzymane tym sposobem | |
| PL2791201T3 (pl) | Sposób wytwarzania określonych funkcjonalnych oligomerów kwasu mlekowego | |
| SG11201405376TA (en) | CRYSTALLINE FORMS OF 5α-ANDROSTANE-3β, 5, 6β-TRIOL AND PREPARATION METHODS THEREOF | |
| WO2013114397A3 (en) | Pharmaceutically acceptable salt of brinzolamide and composition thereof | |
| GB2527958A (en) | Pregnane-oximino-aminoalkylethers and process for preparation thereof, useful as antidiabetic and antidyslipidemic agents |